Struggling Eisai gets FDA approval for cancer drug Halaven for liposarcoma

Eric Palmer

Japan's got a much-needed boost on Thursday when the FDA approved its , , for treatment of for patients in which the cancer has advanced to the point where surgery is not an option.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS